Purines 2010: Adenine Nucleosides and Nucleotides in Biomedicine

IDrugs. 2010 Aug;13(8):534-8.

Abstract

The Purines 2010: Adenine Nucleosides and Nucleotides in Biomedicine meeting, held in Tarragona, Spain, included topics covering new findings in the field of purinergic signaling and the development of purine-based drugs. This conference report highlights selected presentations on developments in purinerigic signaling, medicinal chemistry, the therapeutic potential of purine-based drugs, and the role of purines and adenosine receptors in neurodegenerative disorders, sickle cell disease, bone homeostasis, pulmonary fibrosis and pain. Investigational drugs discussed include CF-101 (Can-Fite BioPharma Ltd/NIH/Kwang Dong Pharmaceutical Co Ltd/Seikagaku Corp) and denufosol tetrasodium (Cystic Fibrosis Foundation Therapeutics Inc/Inspire Pharmaceuticals Inc).

Publication types

  • Congress

MeSH terms

  • Adenine Nucleotides / therapeutic use*
  • Adenosine / analogs & derivatives*
  • Adenosine / therapeutic use*
  • Anemia, Sickle Cell / drug therapy
  • Anemia, Sickle Cell / metabolism
  • Bone and Bones / metabolism
  • Cystic Fibrosis / drug therapy
  • Cystic Fibrosis / metabolism
  • Drug Design
  • Drugs, Investigational / therapeutic use*
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / metabolism
  • Neurodegenerative Diseases / drug therapy
  • Neurodegenerative Diseases / metabolism
  • Pain / drug therapy
  • Pain / metabolism
  • Pulmonary Fibrosis / drug therapy
  • Pulmonary Fibrosis / metabolism
  • Receptors, Purinergic / physiology
  • Signal Transduction

Substances

  • Adenine Nucleotides
  • Drugs, Investigational
  • Receptors, Purinergic
  • Adenosine